MoneyWorks4Me

Mangalam Drugs & Organics submits copy of revise financial results

19 Jul 2013 Evaluate

Mangalam Drugs & Organics has submitted a copy of revise Financial Results for the quarter and year ended March 31, 2013. The heading of the first column change from 'Unaudited - 3 months ended - March 31, 2013' to 'Audited - 3 months ended - March 31, 2013 - refer note no. 2'. There is no change in any of the financial figures submitted earlier.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1250.00
Cipla 1383.00
Lupin 2060.00
Zydus Lifesciences 1195.20
View more..